Cuts have eliminated more than a dozen U.S. government health-tracking programs
More than a dozen data-gathering programs that track deaths and disease appear to have been eliminated in the tornado of layoffs and proposed budget cuts rolled out in the Trump administration's first 100 days.
The Associated Press examined draft and final budget proposals and spoke to more than a dozen current and former federal employees to determine the scope of the cuts to programs tracking basic facts about Americans' health.
Among those terminated at the Centers for Disease Control and Prevention were experts tracking abortions, pregnancies, job-related injuries, lead poisonings, sexual violence and youth smoking, the AP found.
'If you don't have staff, the program is gone,' said Patrick Breysse, who used to oversee the CDC's environmental health programs.
Federal officials have not given a public accounting of specific surveillance programs that are being eliminated.
Instead, a U.S. Department of Health and Human Services spokeswoman pointed the AP to a Trump administration budget proposal released Friday. It lacked specifics, but proposes to cut the CDC's core budget by more than half and vows to focus CDC surveillance only on emerging and infectious diseases.
Kennedy has said some of the CDC's other work will be moved to a yet-to-be-created agency, the Administration for a Healthy America. He also has said that the cuts are designed to get rid of waste at a department that has seen its budget grow in recent years.
'Unfortunately, this extra spending and staff has not improved our nation's health as a country,' Kennedy wrote last month in the New York Post. 'Instead, it has only created more waste, administrative bloat and duplication.'
Some health experts say the eliminated programs are not duplicative, and erasing them will leave Americans in the dark.
'If the U.S. is interested in making itself healthier again, how is it going to know, if it cancels the programs that helps us understand these diseases?' said Graham Mooney, a Johns Hopkins University public health historian.
The core of the nation's health surveillance is done by the CDC's National Center for Health Statistics. Relying on birth and death certificates, it generates information on birth rates, death trends and life expectancy. It also operates long-standing health surveys that provide basic data on obesity, asthma and other health issues.
The center has been barely touched in layoffs, and seems intact under current budget plans.
But many other efforts were targeted by the cuts, the AP found. Some examples:
The Pregnancy Risk Assessment Monitoring System, which surveys women across the country, lost its entire staff — about 20 people.
It's the most comprehensive collection of data on the health behaviors and outcomes before, during and after childbirth. Researchers have been using its data to investigate the nation's maternal mortality problem.
Recent layoffs also wiped out the staffs collecting data on in vitro fertilizations and abortions.
Those cuts come despite President Trump's assertions he wants to expand IVF access and that the Heritage Foundation's Project 2025 playbook for his administration called for more abortion surveillance.
The CDC eliminated its program on lead poisoning in children, which helped local health departments — through funding and expertise — investigate lead poisoning clusters and find where risk is greatest.
Lead poisoning in kids typically stems from exposure to bits of old paint, contaminated dust or drinking water that passes through lead pipes. But the program's staff also played an important role in the investigation of lead-tainted applesauce that affected 500 kids.
Last year, Milwaukee health officials became aware that peeling paint in aging local elementary schools was endangering kids. The city health department began working with the CDC to test tens of thousands of students. That assistance stopped last month when the CDC's lead program staff was terminated.
City officials are particularly concerned about losing expertise to help them track the long-term effects.
'We don't know what we don't know,' said Mike Totoraitis, the city's health commissioner.
Also gone is the staff for the 23-year-old Environmental Public Health Tracking Program, which had information on concerns including possible cancer clusters and weather-related illnesses.
'The loss of that program is going to greatly diminish the ability to make linkages between what might be in the environment and what health might be affected by that,' Breysse said.
In some cases, it's not a matter of staffers leaving, but rather the end of specific types of data collection.
Transgender status is no longer being recorded in health-tracking systems, including ones focused on violent deaths and on risky behaviors by kids.
Experts know transgender people are more likely to be victims of violence, but now 'it's going to be much more challenging to quantify the extent to which they are at higher risk,' said Thomas Simon, the recently retired senior director for scientific programs at the CDC's Division of Violence Prevention.
The staff and funding seem to have remained intact for a CDC data collection that provides insights into homicides, suicides and accidental deaths involving weapons.
But CDC violence-prevention programs that acted on that information were halted. So, too, was work on a system that collects hospital data on nonfatal injuries from causes such as shootings, crashes and drownings.
Also going away, apparently, is the CDC's National Intimate Partner and Sexual Violence Survey. The system is designed to pick up information that's not found in law enforcement statistics. Health officials see that work as important, because not all sexual violence victims go to police.
The National Institute for Occupational Safety and Health, which tracks job-related illnesses and deaths and makes recommendations on how to prevent them, was gutted by the cuts.
Kennedy has said that 20% of the people laid off might be reinstated as the agency tries to correct mistakes.
That appeared to happen last month, when the American Federation of Government Employees said that NIOSH workers involved in a black lung disease program for coal miners had been temporarily called back.
But Health and Human Services Department officials did not answer questions about the reinstatement. The American Federation of Government Employees' Micah Niemeier-Walsh later said the workers continued to have June termination dates and 'we are concerned this is to give the appearance that the programs are still functioning, when effectively they are not.'
There's been no talk of salvaging some other NIOSH programs, including one focused on workplace deaths in the oil and gas industries or a research project into how common hearing loss is in that industry.
The Health and Human Services cuts eliminated the 17-member team responsible for the National Survey on Drug Use and Health, one of the main ways the government measures drug use.
Also axed were the CDC staff working on the National Youth Tobacco Survey.
There are other surveys that look at youth smoking and drug use, including the University of Michigan's federally funded 'Monitoring the Future' survey of schoolkids.
But the federal studies looked at both adults and adolescents, and provided insights into drug use by high school dropouts. The CDC also delved into specific vaping and tobacco products in the ways that other surveys don't, and was a driver in the federal push to better regulate electronic cigarettes.
'There was overlap among the surveys, but each one had its own specific focus that the other ones didn't cover,' said Richard Miech, who leads the Michigan study.
Work to modernize data collection has been derailed. That includes an upgrade to a 22-year-old system that helps local public health departments track diseases and allows CDC to put together a national picture.
Another casualty was the Center for Forecasting and Outbreak Analytics, which tries to predict disease trends.
The center, created during the height of the COVID-19 pandemic, was working on forecasting the current multistate measles outbreak. That forecast hasn't been published partly because of the layoffs, according to two CDC officials who spoke on condition of anonymity because they are not authorized to discuss it and fear retribution for speaking to the press.
Trump hasn't always supported widespread testing of health problems.
In the spring of 2020, when COVID-19 diagnoses were exploding, the president groused that the nation's ability to do more testing was making the U.S. look like it had a worse problem than other countries. He called testing 'a double-edged sword.'
Mooney, the Johns Hopkins historian, wonders how interested the new administration is in reporting on health problems.
'You could think it's deliberate,' he said. 'If you keep people from knowing, they're less likely to be concerned.'
Stobbe writes for the Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Majority of Americans think alcohol bad for health: poll
A narrow majority of Americans now believe even moderate consumption of alcohol negatively affects health, as US drinking levels continue to decline, according to a recent survey. Pollster Gallup found the number of Americans who said they drink alcohol to be at an all-time low since the poll was first conducted in 1939 -- a few years after the United States ended its prohibition of alcohol. The survey found 54 percent of Americans reported they drank alcohol either occasionally or regularly in 2025, down from at least 60 percent recorded between 1997 and 2023. Those who did say they drank alcohol reported it was in smaller amounts, with the average number of drinks consumed in the last week being 2.8, "the lowest figure Gallup has recorded since 1996," the pollster said on its website. Attitudes toward alcohol, which Gallup has been tracking since 2001, saw the most significant difference in the poll published this week. The number of people who consider moderate consumption of alcohol -- up to one or two drinks per day -- to be bad for personal health rose to 53 percent in 2025. For comparison, the figure was 27 percent in the early 2000s. "Americans' drinking habits are shifting amid the medical world's reappraisal of alcohol's health effects," the pollster noted. In January, then-US surgeon general Vivek Murthy called for alcohol to be sold with a cancer warning label on its packaging. "Alcohol is a well-established, preventable cause of cancer, responsible for about 100,000 cancer cases and 20,000 cancer deaths annually in the United States," he said in a statement. "Yet the majority of Americans are unaware of this risk," he added, underscoring the urgent need for public education. cha/aem/jgc/dl
Yahoo
7 hours ago
- Yahoo
Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst
Eli Lilly (LLY) raised prices of its GLP-1 weight-loss injectable in the UK this week, with plans to do the same in other European countries, in response to President Trump's push to normalize pricing in peer developed nations. The effort, known as Most Favored Nations pricing, has been a goal of Trump's since his first term. He has doubled down on the efforts this year, giving pharma companies 60 days to implement changes in pricing in what he deems "freeloading" nations. The US drug economy differs from European and other developed nations, which rely on the government to negotiate prices with drugmakers, resulting in lower prices globally. "While we agree that the costs for breakthrough medicines should be more fairly shared across developed countries, we must also address the underlying structural issues in the US that have contributed to high drug prices. The US system is complex and opaque," Lilly said in a statement Thursday. The stock was up 1% in trading Friday. Eli Lilly raised the price of its GLP-1, Zepbound, from about $125 to $165 and plans an additional hike next month that would almost double its price. In a note to clients Friday, Bank of America Securities research analyst Tim Anderson questioned who would actually be impacted by the raised prices. "LLY has announced it will raise GLP-1 pricing in the UK by a healthy margin (a doubling of price, but it's unclear to whom this higher price realistically applies). It expects to do something similar in other European countries (but worth appreciating: in most European markets, there aren't price agreements in place between GLP-1 manufacturers and governments, meaning these are out-of-pocket spending markets)," Anderson wrote. Ultimately, whether or not the move results in lower US prices remains a question, though Anderson believes it likely will not. "Does this mean it will actually cut the price on the GLP-1s in the US (and on other medicines)? To us, the answer is quite likely no, or at least, not in a way that creates P&L [profit and loss planning ] risk," he wrote. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Axios
8 hours ago
- Axios
At-home cervical cancer test rolls out in California
The first FDA-approved at-home cervical cancer screening device launched this week in California. Why it matters: Cervical cancer is largely preventable, yet 1 in 4 U.S. women aren't up to date on screenings for the disease, per the CDC. Teal Health's goal is to make the testing experience feel less invasive than a Pap smear, which can often cause pain. Driving the news: The Teal Wand allows people to self-collect a vaginal sample to test for HPV, the virus that causes nearly all cervical cancers. The San Francisco women's health company spearheading the device says it uses the same HPV test used in clinics and merely differs in the method of collection. The big picture: California records about 7.3 cervical cancer cases per 100,000 people every year, slightly under the national rate of 7.5. The incidence rate varies among racial groups, however, with Hispanics generally seeing higher figures. Nationwide, Black and Indigenous people also experience higher rates of cervical cancer and mortality compared to white women. "Several studies have shown that the availability of self-screening can boost participation in cervical cancer screening among underscreened persons—a population most likely to benefit in terms of cancer prevention," UCSF obstetrician-gynecologist George F. Sawaya told Axios via email. In 2023, cervical cancer screenings in the U.S. remained 14% lower than pre-pandemic levels, per a March journal article. Yes, but: It's equally critical to ensure those with positive test results get reliable follow-ups and treatment, Sawaya added. How it works: To take a sample, the wand — similar to a tampon in its dimensions — is inserted into the vagina and deploys a sponge to collect cells from the cervix. Once the sponge is extracted, it's placed in a vial and mailed to the lab. Teal medical providers then review the results and follow up via telehealth. The kit, which is shipped to your door, is available for purchase online and costs $99 with in-network insurance and $249 via credit card or HSA/FSA payment. By the numbers: Self-collected samples using the wand have proven to detect cervical precancer 96% of the time, similar to clinician-collected ones, Teal Health's 16-site clinical trials found. Eighty-six percent of participants said they'd be more likely to stay up to date with screenings if they could do it at home, per the trials. What they're saying: A lot of people don't recognize the importance of getting tested regularly because it's not always clear what a Pap smear is for, Teal Health co-founder and CEO Kara Egan told Axios. Lack of appointments, time conflicts and discomfort with the exam are also top reasons for not screening, Egan added. The wand was designed to alleviate those concerns, she said, offering the "same accuracy, but just comfortably and privately from home."